MBA, President and CEO, Labcyte
Mr. Fischer-Colbrie became president and CEO of Labcyte in September 2008. He has more than 30 years of experience in launching novel diagnostics, medical devices, therapeutics and high technology for growth companies, building from start-up through IPO and into high revenue levels. Prior to joining Labcyte, Mr. Fischer-Colbrie was senior vice president of finance and administration and chief financial officer at Adeza Biomedical Corporation, a women’s health care start-up company, which went public in December 2004. The company was subsequently sold for $450 million. During his tenure at Adeza, Mr. Fischer-Colbrie was the inventor on 3 patents and 6 patent applications and led the business development function for three years. Mr. Fischer-Colbrie holds a B.A. from Stanford University and an M.B.A. in Marketing and Finance from the University of California at Berkeley.